DKT is one of the largest private providers of family planning and reproductive health products and services, providing couples with affordable and safe options for family planning and HIV/AIDS prevention, so they can live empowered lives free from the fear of unwanted pregnancy or sexually transmitted diseases.
As the world continues to grapple with the HIV epidemic, DKT launches a major breakthrough in HIV testing amid COVID-19 pandemic.
The first in-home ORAL HIV SELF-TEST KIT – “OraQuick”.
OraQuick detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. It is the first in-home ORAL HIV SELF-TEST to be approved by WHO, NAFDAC, FMOH and US-FDA.
For the first time ever, individuals will have access to an in-home oral test that will empower them to learn their HIV status in the comfort and privacy of their homes. This new in-home rapid test will help individuals at risk for HIV who may not want to test in a clinical setting especially in COVID-19 pandemic times.
OraQuick Oral HIV Self-Test is 99% accurate, very easy to use (just swipe your gum), delivers result in 20 minutes, and it is seen only by you (thus providing confidentiality and preventing HIV-related stigma).
The Oral HIV Self-Test Kit is available in pharmacies and online stores.
